172 related articles for article (PubMed ID: 24630183)
1. Hemoglobin levels in persons with depressive and/or anxiety disorders.
Lever-van Milligen BA; Vogelzangs N; Smit JH; Penninx BW
J Psychosom Res; 2014 Apr; 76(4):317-21. PubMed ID: 24630183
[TBL] [Abstract][Full Text] [Related]
2. Exposure to secondhand smoke and depression and anxiety: a report from two studies in the Netherlands.
Bot M; Vink JM; Willemsen G; Smit JH; Neuteboom J; Kluft C; Boomsma DI; Penninx BW
J Psychosom Res; 2013 Nov; 75(5):431-6. PubMed ID: 24182631
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders.
Thesing CS; Bot M; Milaneschi Y; Giltay EJ; Penninx BWJH
Psychoneuroendocrinology; 2018 Jan; 87():53-62. PubMed ID: 29040890
[TBL] [Abstract][Full Text] [Related]
4. Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users.
Bot M; Milaneschi Y; Penninx BW; Drent ML
Psychoneuroendocrinology; 2016 Jun; 68():148-55. PubMed ID: 26974499
[TBL] [Abstract][Full Text] [Related]
5. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation.
Vogelzangs N; Duivis HE; Beekman AT; Kluft C; Neuteboom J; Hoogendijk W; Smit JH; de Jonge P; Penninx BW
Transl Psychiatry; 2012 Feb; 2(2):e79. PubMed ID: 22832816
[TBL] [Abstract][Full Text] [Related]
6. The impact of lifestyle factors on the 2-year course of depressive and/or anxiety disorders.
Boschloo L; Reeuwijk KG; Schoevers RA; W J H Penninx B
J Affect Disord; 2014 Apr; 159():73-9. PubMed ID: 24679393
[TBL] [Abstract][Full Text] [Related]
7. Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA).
Penninx BW; Nolen WA; Lamers F; Zitman FG; Smit JH; Spinhoven P; Cuijpers P; de Jong PJ; van Marwijk HW; van der Meer K; Verhaak P; Laurant MG; de Graaf R; Hoogendijk WJ; van der Wee N; Ormel J; van Dyck R; Beekman AT
J Affect Disord; 2011 Sep; 133(1-2):76-85. PubMed ID: 21496929
[TBL] [Abstract][Full Text] [Related]
8. Depressive and anxiety disorders and risk of subclinical atherosclerosis Findings from the Netherlands Study of Depression and Anxiety (NESDA).
Seldenrijk A; Vogelzangs N; van Hout HP; van Marwijk HW; Diamant M; Penninx BW
J Psychosom Res; 2010 Aug; 69(2):203-10. PubMed ID: 20624520
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil gelatinase-associated lipocalin: a novel inflammatory marker associated with late-life depression.
Naudé PJ; Eisel UL; Comijs HC; Groenewold NA; De Deyn PP; Bosker FJ; Luiten PG; den Boer JA; Oude Voshaar RC
J Psychosom Res; 2013 Nov; 75(5):444-50. PubMed ID: 24182633
[TBL] [Abstract][Full Text] [Related]
10. Depression, anxiety and 6-year risk of cardiovascular disease.
Seldenrijk A; Vogelzangs N; Batelaan NM; Wieman I; van Schaik DJ; Penninx BJ
J Psychosom Res; 2015 Feb; 78(2):123-9. PubMed ID: 25454680
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease in persons with depressive and anxiety disorders.
Vogelzangs N; Seldenrijk A; Beekman AT; van Hout HP; de Jonge P; Penninx BW
J Affect Disord; 2010 Sep; 125(1-3):241-8. PubMed ID: 20223521
[TBL] [Abstract][Full Text] [Related]
12. Association between anxiety disorders and heart rate variability in The Netherlands Study of Depression and Anxiety (NESDA).
Licht CM; de Geus EJ; van Dyck R; Penninx BW
Psychosom Med; 2009 Jun; 71(5):508-18. PubMed ID: 19414616
[TBL] [Abstract][Full Text] [Related]
13. The association of social support at work and in private life with mental health and antidepressant use: the Health 2000 Study.
Sinokki M; Hinkka K; Ahola K; Koskinen S; Kivimäki M; Honkonen T; Puukka P; Klaukka T; Lönnqvist J; Virtanen M
J Affect Disord; 2009 May; 115(1-2):36-45. PubMed ID: 18722019
[TBL] [Abstract][Full Text] [Related]
14. Generalized anxiety disorder in patients with major depression: is DSM-IV's hierarchy correct?
Zimmerman M; Chelminski I
Am J Psychiatry; 2003 Mar; 160(3):504-12. PubMed ID: 12611832
[TBL] [Abstract][Full Text] [Related]
15. Cytokine production capacity in depression and anxiety.
Vogelzangs N; de Jonge P; Smit JH; Bahn S; Penninx BW
Transl Psychiatry; 2016 May; 6(5):e825. PubMed ID: 27244234
[TBL] [Abstract][Full Text] [Related]
16. Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders.
van Mill JG; Hoogendijk WJ; Vogelzangs N; van Dyck R; Penninx BW
J Clin Psychiatry; 2010 Mar; 71(3):239-46. PubMed ID: 20331928
[TBL] [Abstract][Full Text] [Related]
17. Depressive and anxiety disorders in women with HIV infection.
Morrison MF; Petitto JM; Ten Have T; Gettes DR; Chiappini MS; Weber AL; Brinker-Spence P; Bauer RM; Douglas SD; Evans DL
Am J Psychiatry; 2002 May; 159(5):789-96. PubMed ID: 11986133
[TBL] [Abstract][Full Text] [Related]
18. Sleep duration, but not insomnia, predicts the 2-year course of depressive and anxiety disorders.
van Mill JG; Vogelzangs N; van Someren EJ; Hoogendijk WJ; Penninx BW
J Clin Psychiatry; 2014 Feb; 75(2):119-26. PubMed ID: 24345733
[TBL] [Abstract][Full Text] [Related]
19. Disorder-specific automatic self-associations in depression and anxiety: results of The Netherlands Study of Depression and Anxiety.
Glashouwer KA; de Jong PJ
Psychol Med; 2010 Jul; 40(7):1101-11. PubMed ID: 19811700
[TBL] [Abstract][Full Text] [Related]
20. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA).
Duivis HE; Vogelzangs N; Kupper N; de Jonge P; Penninx BW
Psychoneuroendocrinology; 2013 Sep; 38(9):1573-85. PubMed ID: 23399050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
